Immunome, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0 | 0 | 0 | 4.0M | 2.9M | 2.7M | 2.9M | 2.4M |
| Cost of Goods Sold | 753K | 0 | 49.2M | 720K | 0 | 0 | 0 | 0 |
| Gross Profit | -753K | 0 | -49.2M | 3.3M | 2.9M | 2.7M | 2.9M | 2.4M |
| R&D Expenses | 46.4M | 60.8M | 49.2M | 40.5M | 36.9M | 47.9M | 37.2M | 29.1M |
| Operating Expenses | 58.6M | 72.9M | 10.9M | 49.8M | 47.6M | 85.7M | 53.4M | 42.4M |
| Operating Income | -59.3M | -72.9M | -60.1M | -46.5M | -44.6M | -83.0M | -50.5M | -40.0M |
| Other Income / Gains | 5.5M | 3.0M | 2.7M | 3.1M | 3.0M | 2.7M | 3.4M | 3.9M |
| Net Income | -53.8M | -69.9M | -57.5M | -43.4M | -41.6M | -80.2M | -47.1M | -36.1M |
| EPS (Diluted) | -0.48 | -0.76 | -0.65 | -0.50 | -0.52 | -1.28 | -0.78 | -0.60 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0 | 0 | 0 | 0.821 | 1.00 | 1.00 | 1.00 | 1.00 |
| General And Administrative Expenses | 12.9M | 12.1M | 10.9M | 10.0M | 10.7M | 10.4M | 9.5M | 7.0M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 12.9M | 12.1M | 10.9M | 10.0M | 10.7M | 10.4M | 9.5M | 7.0M |
| Other Expenses | -753K | 0 | -49.2M | -720K | 0 | 27.4M | 6.7M | 6.3M |
| Cost And Expenses | 59.3M | 72.9M | 60.1M | 50.5M | 47.6M | 85.7M | 53.4M | 42.4M |
| Interest Income | 5.5M | 3.0M | 2.7M | 3.1M | 3.0M | 2.7M | 3.4M | 3.9M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 753K | 776K | 589K | 720K | 726K | 595K | 571K | 673K |
| Ebitda | -53.1M | -69.1M | -56.9M | -42.7M | -40.9M | -55.0M | -43.2M | -33.0M |
| Ebitdaratio | 0 | 0 | 0 | -10.629 | -13.983 | -20.089 | -14.861 | -13.97 |
| Operating Income Ratio | 0 | 0 | 0 | -11.576 | -15.255 | -30.303 | -17.362 | -16.924 |
| Income Before Tax | -53.8M | -69.9M | -57.5M | -43.4M | -41.6M | -80.2M | -47.1M | -36.1M |
| Income Before Tax Ratio | 0 | 0 | 0 | -10.809 | -14.231 | -29.309 | -16.186 | -15.28 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | 0 | 0 | 0 | -10.809 | -14.231 | -29.309 | -16.186 | -15.28 |
| Epsdiluted | -0.48 | -0.76 | -0.65 | -0.50 | -0.52 | -1.28 | -0.78 | -0.60 |
| Weighted Average Shs Out | 113.1M | 87.4M | 88.0M | 87.0M | 79.4M | 62.7M | 60.2M | 59.9M |
| Weighted Average Shs Out Dil | 113.1M | 87.4M | 88.0M | 87.0M | 79.4M | 62.7M | 60.2M | 59.9M |